Estrogen News and Research

Latest Estrogen News and Research

Chemotherapy-induced anemia increases risk of local breast cancer recurrence

Patients with breast cancer who developed anemia during chemotherapy had nearly three times the risk of local recurrence as those who did not, according to a study published in the April 1 issue of Clinical Cancer Research¸ a journal of the American Association for Cancer Research.

2 Apr 2008

Why synthetic estrogens wreak havoc on reproductive system

Researchers at Yale School of Medicine now have a clearer understanding of why synthetic estrogens such as those found in many widely-used plastics have a detrimental effect on a developing fetus, cause fertility problems, as well as vaginal and breast cancers.

1 Apr 2008

Keeping in good shape in old age is harder for women

Women aged 65-plus find it harder than men of the same age to preserve muscle - which probably impacts on their ability to stay as strong and fit, according to new research.

28 Mar 2008

Targeting aggressive breast cancers by putting them to sleep

It is well established that Id1, a gene normally produced only in embryonic development, is reactivated in many 'solid' cancers, or carcinomas.

26 Mar 2008

Hormonal contraception for men

Hormonal contraception may become a safe, effective, and reversible form of birth control for men, according to a new study accepted for publication in the Journal of Clinical Endocrinology & Metabolism (JCEM).

26 Mar 2008

Physical therapy helps symptoms of urinary incontinence in women

A study published in the Annals of Internal Medicine (March 18, 2008) reports that pelvic floor muscle training, in conjunction with bladder training, resolved the symptoms of urinary incontinence in women.

20 Mar 2008

HRT users and non-HRT users benefited equally from the exercise

Aerobic exercise significantly decreased the chemical imbalances that can lead to heart disease and stroke in postmenopausal women according to a study in the spring issue of the Journal of Women and Aging.

19 Mar 2008

BMI may serve as prognostic tool for advanced, aggressive breast cancers

Body Mass Index (BMI), the measure of a person's fat based on their height and weight, may be an effective prognostic tool for specific types of breast cancer, according to research from The University of Texas M. D. Anderson Cancer Center.

17 Mar 2008

Long-term effects of synthetic progestins cause for concern

The widely used synthetic progestin medroxyprogesterone acetate (MPA) decreased endothelial function in premenopausal women in a study done at the University of Oregon.

11 Mar 2008

Late treatment with letrozole (Femara) can reduce breast cancer recurrence risk

Treatment with the aromatase inhibitor letrozole (Femara) can reduce the risk of breast cancer recurrence even when initiated one to seven years after a course of tamoxifen therapy.

11 Mar 2008

Femara helps protect against return of breast cancer after completing Tamoxifen therapy

Women may reduce the risk of their breast cancer returning by starting treatment with Femara (letrozole tablets) anywhere from one to seven years after finishing tamoxifen therapy, according to a new analysis published in the Journal of Clinical Oncology.

11 Mar 2008

Cruciferous vegetables may lower risk for breast cancer

When your mother told you to eat your vegetables it appears that maternal wisdom had a scientific basis.

10 Mar 2008

Risks of long-term hormone therapy continue to outweigh benefits

New results from the Women's Health Initiative (WHI) confirm that the health risks of long-term use of combination (estrogen plus progestin) hormone therapy in healthy, postmenopausal women persist even a few years after stopping the drugs and clearly outweigh the benefits.

6 Mar 2008

Cancer risk slightly higher for women in discontinued hormone treatment trial

A follow up study of participants in the Women's Health Initiative (WHI) clinical trial led by a University of North Carolina at Chapel Hill researcher has found that women who were taking the combined hormone therapy of estrogen plus progestin may have an increased risk of cancer since the intervention was stopped, compared to participants in the trial's placebo group.

6 Mar 2008

Cancer risk from HRT remains long after treatment has stopped

The results of a new study have shown that the risk of cancer associated with Hormone Replacement Therapy (HRT) continues long after a woman stops taking it.

5 Mar 2008

Tamoxifen may help treat mania in patients with bipolar disorder

A small, three-week trial of tamoxifen, a drug typically used to treat breast cancer, indicates that it also may decrease symptoms of mania in patients with bipolar disorder, according to a report in the March issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

4 Mar 2008